🇺🇸 FDA
Pipeline program

MNPR-101-DFO*-89Zr

MNPR-101-D001

Phase 1 small_molecule active

Quick answer

MNPR-101-DFO*-89Zr for Solid Tumor, Adult is a Phase 1 program (small_molecule) at Monopar Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Monopar Therapeutics
Indication
Solid Tumor, Adult
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials